Osaic Holdings’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $213K | Buy |
4,968
+248
| +5% | +$10.6K | ﹤0.01% | 3554 |
|
|
2025
Q1 | $207K | Buy |
4,720
+78
| +2% | +$3.42K | ﹤0.01% | 3596 |
|
|
2024
Q4 | $200K | Sell |
4,642
-2,572
| -36% | -$111K | ﹤0.01% | 3592 |
|
|
2024
Q3 | $320K | Sell |
7,214
-245
| -3% | -$10.9K | ﹤0.01% | 3259 |
|
|
2024
Q2 | $297K | Buy |
7,459
+488
| +7% | +$19.4K | ﹤0.01% | 3230 |
|
|
2024
Q1 | $301K | Buy |
6,971
+675
| +11% | +$29.1K | ﹤0.01% | 3340 |
|
|
2023
Q4 | $262K | Buy |
6,296
+118
| +2% | +$4.91K | ﹤0.01% | 3700 |
|
|
2023
Q3 | $246K | Buy |
6,178
+399
| +7% | +$15.9K | ﹤0.01% | 3849 |
|
|
2023
Q2 | $237K | Sell |
5,779
-1,125
| -16% | -$46.1K | ﹤0.01% | 3754 |
|
|
2023
Q1 | $284K | Buy |
6,904
+257
| +4% | +$10.6K | ﹤0.01% | 3595 |
|
|
2022
Q4 | $272K | Buy |
6,647
+2,910
| +78% | +$119K | ﹤0.01% | 3588 |
|
|
2022
Q3 | $150K | Sell |
3,737
-18,511
| -83% | -$743K | ﹤0.01% | 4017 |
|
|
2022
Q2 | $935K | Buy |
22,248
+17,340
| +353% | +$729K | ﹤0.01% | 2343 |
|
|
2022
Q1 | $222K | Sell |
4,908
-136
| -3% | -$6.15K | ﹤0.01% | 3946 |
|
|
2021
Q4 | $233K | Sell |
5,044
-842
| -14% | -$38.9K | ﹤0.01% | 3810 |
|
|
2021
Q3 | $280K | Buy |
5,886
+1,667
| +40% | +$79.3K | ﹤0.01% | 3608 |
|
|
2021
Q2 | $218K | Sell |
4,219
-9,488
| -69% | -$490K | ﹤0.01% | 3798 |
|
|
2021
Q1 | $691K | Buy |
13,707
+1,987
| +17% | +$100K | ﹤0.01% | 2550 |
|
|
2020
Q4 | $610K | Buy |
11,720
+6,420
| +121% | +$334K | ﹤0.01% | 2461 |
|
|
2020
Q3 | $230K | Buy |
5,300
+2,000
| +61% | +$86.8K | ﹤0.01% | 3106 |
|
|
2020
Q2 | $141K | Sell |
3,300
-710
| -18% | -$30.3K | ﹤0.01% | 3421 |
|
|
2020
Q1 | $145K | Buy |
+4,010
| New | +$145K | ﹤0.01% | 3157 |
|